These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
366 related items for PubMed ID: 21831680
1. Pharmacophore filtering and 3D-QSAR in the discovery of new JAK2 inhibitors. Dhanachandra Singh Kh, Karthikeyan M, Kirubakaran P, Nagamani S. J Mol Graph Model; 2011 Sep; 30():186-97. PubMed ID: 21831680 [Abstract] [Full Text] [Related]
2. Structural insights of JAK2 inhibitors: pharmacophore modeling and ligand-based 3D-QSAR studies of pyrido-indole derivatives. Gade DR, Kunala P, Raavi D, Reddy PK, Prasad RV. J Recept Signal Transduct Res; 2015 Apr; 35(2):189-201. PubMed ID: 25140764 [Abstract] [Full Text] [Related]
3. 3D-QSAR studies of some tetrasubstituted pyrazoles as COX-II inhibitors. Gupta GK, Kumar A. Acta Pol Pharm; 2012 Apr; 69(4):763-72. PubMed ID: 22876620 [Abstract] [Full Text] [Related]
4. Design of novel FLT-3 inhibitors based on dual-layer 3D-QSAR model and fragment-based compounds in silico. Shih KC, Lin CY, Chi HC, Hwang CS, Chen TS, Tang CY, Hsiao NW. J Chem Inf Model; 2012 Jan 23; 52(1):146-55. PubMed ID: 22142286 [Abstract] [Full Text] [Related]
5. Development of in silico models for pyrazoles and pyrimidine derivatives as cyclin-dependent kinase 2 inhibitors. Wang F, Ma Z, Li Y, Zhu S, Xiao Z, Zhang H, Wang Y. J Mol Graph Model; 2011 Sep 23; 30():67-81. PubMed ID: 21763166 [Abstract] [Full Text] [Related]
6. BCR-ABL tyrosine kinase inhibitor pharmacophore model derived from a series of phenylaminopyrimidine-based (PAP) derivatives. Cui J, Fu R, Zhou LH, Chen SP, Li GW, Qian SX, Liu S. Bioorg Med Chem Lett; 2013 Apr 15; 23(8):2442-50. PubMed ID: 23473682 [Abstract] [Full Text] [Related]
7. Pharmacophore modeling, virtual screening and 3D-QSAR studies of 5-tetrahydroquinolinylidine aminoguanidine derivatives as sodium hydrogen exchanger inhibitors. Bhatt HG, Patel PK. Bioorg Med Chem Lett; 2012 Jun 01; 22(11):3758-65. PubMed ID: 22546667 [Abstract] [Full Text] [Related]
8. Pharmacophore modeling and virtual screening to identify potential RET kinase inhibitors. Shih KC, Shiau CW, Chen TS, Ko CH, Lin CL, Lin CY, Hwang CS, Tang CY, Chen WR, Huang JW. Bioorg Med Chem Lett; 2011 Aug 01; 21(15):4490-7. PubMed ID: 21724393 [Abstract] [Full Text] [Related]
16. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification. Islam MA, Pillay TS. J Mol Graph Model; 2015 Mar 01; 56():20-30. PubMed ID: 25541527 [Abstract] [Full Text] [Related]